1. Home
  2. AMPS vs PCRX Comparison

AMPS vs PCRX Comparison

Compare AMPS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPS
  • PCRX
  • Stock Information
  • Founded
  • AMPS 2009
  • PCRX 2006
  • Country
  • AMPS United States
  • PCRX United States
  • Employees
  • AMPS N/A
  • PCRX N/A
  • Industry
  • AMPS Electric Utilities: Central
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMPS Utilities
  • PCRX Health Care
  • Exchange
  • AMPS Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • AMPS 608.0M
  • PCRX 604.7M
  • IPO Year
  • AMPS N/A
  • PCRX 2011
  • Fundamental
  • Price
  • AMPS $3.82
  • PCRX $22.36
  • Analyst Decision
  • AMPS Strong Buy
  • PCRX Buy
  • Analyst Count
  • AMPS 9
  • PCRX 10
  • Target Price
  • AMPS $5.38
  • PCRX $27.60
  • AVG Volume (30 Days)
  • AMPS 1.4M
  • PCRX 798.1K
  • Earning Date
  • AMPS 11-12-2024
  • PCRX 02-27-2025
  • Dividend Yield
  • AMPS N/A
  • PCRX N/A
  • EPS Growth
  • AMPS N/A
  • PCRX N/A
  • EPS
  • AMPS 0.22
  • PCRX N/A
  • Revenue
  • AMPS $185,992,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • AMPS $30.56
  • PCRX $4.83
  • Revenue Next Year
  • AMPS $17.93
  • PCRX $2.16
  • P/E Ratio
  • AMPS $17.32
  • PCRX N/A
  • Revenue Growth
  • AMPS 25.90
  • PCRX 4.40
  • 52 Week Low
  • AMPS $2.71
  • PCRX $11.16
  • 52 Week High
  • AMPS $7.28
  • PCRX $34.01
  • Technical
  • Relative Strength Index (RSI)
  • AMPS 43.69
  • PCRX 70.92
  • Support Level
  • AMPS $3.82
  • PCRX $18.18
  • Resistance Level
  • AMPS $4.24
  • PCRX $22.36
  • Average True Range (ATR)
  • AMPS 0.24
  • PCRX 1.13
  • MACD
  • AMPS -0.06
  • PCRX 0.30
  • Stochastic Oscillator
  • AMPS 4.64
  • PCRX 93.11

About AMPS Altus Power Inc.

Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: